Actually, it's the only possibility. You're absolutely right. And in fact, most of these studies are carried out internationally. Even the follow-up registries that monitor ongoing safety and effectiveness work only if they are international. I think that's why we go back to saying that if we had a separate process—That process, though, needs to be linked internationally. In no way can it be a stand-alone process.
In fact, the cobbled response to Fabry disease and the MPS disease—The CDR turned it down. Strong advocacy got the government to come back. All the health ministers came back and said, fine, we'll put together a research project. And quite frankly, we think what they've done is ridiculous. They've created a very tiny little research project all by itself.
We need to be linked, and we need to link those research projects as ongoing registries to international studies. We cannot afford to do this in isolation. Part of our problem, though, is that we end up making these decisions very much in isolation. So you're absolutely right, all of this has to be done internationally. We can learn something only if we do it internationally.